A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative Early-stage Breast Cancer

NCT07890597 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
3800
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer